This page in English

Ove Almkvist

Anknuten

Besöksadress : Novum Pl 5, Hälsovägen7/Blickagången 6 141 57 Huddinge
Postadress : Institutionen för Neurobiologi, Vårdvetenskap och Samhälle (NVS), H1, Sektionen för translationell alzheimer neurobiologi, Novum Pl 5, Blickagången 6/Hälsovägen 7 141 57 Huddinge
Leveransadress : Hälsovägen 7 141 57 Huddinge

Publikationer

Changing everyday activities and technology use in mild cognitive impairment
Hedman A, Nygard L, Malinowsky C, Almkvist O, Kottorp A
BRITISH JOURNAL OF OCCUPATIONAL THERAPY 2016;79(2):111-119

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease
Rodriguez-vieitez E, Saint-aubert L, Carter Sf, Almkvist O, Farid K, Schöll M, et al
Brain : a journal of neurology 2016;139(Pt 3):922-36

Health-adjusted neuropsychological test norms based on 463 older Swedish car drivers
Bergman I, Johansson K, Almkvist O, Lundberg C
Scandinavian journal of psychology 2016;57(2):93-107

Amount and type of everyday technology use over time in older adults with cognitive impairment
Hedman A, Nygård L, Almkvist O, Kottorp A
Scandinavian journal of occupational therapy 2015;22(3):196-206

Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition
Farid K, Carter Sf, Rodriguez-vieitez E, Almkvist O, Andersen P, Wall A, et al
Journal of Alzheimer's disease : JAD 2015;47(3):661-7

Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease
Leuzy A, Carter Sf, Chiotis K, Almkvist O, Wall A, Nordberg A
Journal of Alzheimer's disease : JAD 2015;45(4):1077-88

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment
Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, et al
Journal of Alzheimer's disease : JAD 2015;47(3):691-704

Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case
Almkvist O, Kadir A, Nordberg A
Neurocase 2015;21(6):738-47

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography
Schöll M, Carter Sf, Westman E, Rodriguez-vieitez E, Almkvist O, Thordardottir S, et al
Scientific reports 2015;5():16404-

Including a subject-paced trial may make the PASAT more acceptable for MS patients
Bosnes O, Dahl Op, Almkvist O
Acta neurologica Scandinavica 2015;132(4):219-25

Neuropsychological test norms controlled for physical health: does it matter?
Bergman I, Almkvist O
Scandinavian journal of psychology 2015;56(2):140-50

Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease
Thordardottir S, Ståhlbom Ak, Ferreira D, Almkvist O, Westman E, Zetterberg H, et al
Journal of Alzheimer's disease : JAD 2015;43(4):1393-402

White matter changes in familial Alzheimer's disease
Li X, Westman E, Ståhlbom Ak, Thordardottir S, Almkvist O, Blennow K, et al
Journal of internal medicine 2015;278(2):211-8

Cognitive predictors of medical decision-making capacity in mild cognitive impairment and Alzheimer's disease
Stormoen S, Almkvist O, Eriksdotter M, Sundström E, Tallberg Im
International journal of geriatric psychiatry 2014;29(12):1304-11

Lexical and semantic ability in groups of children with cochlear implants, language impairment and autism spectrum disorder
Löfkvist U, Almkvist O, Lyxell B, Tallberg Im
International journal of pediatric otorhinolaryngology 2014;78(2):253-63

Parent-rated socio-emotional development in children with language impairment in comparison with typically developed children
Aarne P, Almkvist O, Mothander Pr, Tallberg Im
EUROPEAN JOURNAL OF DEVELOPMENTAL PSYCHOLOGY 2014;11(3):279-291

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Nordberg A, Carter Sf, Rinne J, Drzezga A, Brooks Dj, Vandenberghe R, et al
European journal of nuclear medicine and molecular imaging 2013;40(1):104-14

A principal component model of medical health: implications for cognitive deficits and decline among adults in a population-based sample
Persson N, Viitanen M, Almkvist O, Wahlin Å
Journal of health psychology 2013;18(10):1268-87

Callosal atrophy in multiple sclerosis is related to cognitive speed
Bergendal G, Martola J, Stawiarz L, Kristoffersen-wiberg M, Fredrikson S, Almkvist O
Acta neurologica Scandinavica 2013;127(4):281-9

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients
Choo Ih, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A
Journal of Alzheimer's disease : JAD 2013;33(4):929-39

Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease
Darreh-shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom Rp, Nilsson B, et al
Neurobiology of aging 2013;34(11):2465-81

Investigating medical decision-making capacity in patients with cognitive impairment using a protocol based on linguistic features
Tallberg Im, Stormoen S, Almkvist O, Eriksdotter M, Sundström E
Scandinavian journal of psychology 2013;54(5):386-92

Patterns of functioning in older adults with mild cognitive impairment: a two-year study focusing on everyday technology use
Hedman A, Nygård L, Almkvist O, Kottorp A
Aging & mental health 2013;17(6):679-88

Recognition memory for emotional faces in amnestic mild cognitive impairment: An event-related potential study
Schefter M, Werheid K, Almkvist O, Lonnqvist-akenine U, Kathmann N, Winblad B
AGING NEUROPSYCHOLOGY AND COGNITION 2013;20(1):49-79

Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study
Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2013;36(1-2):1-19

The effect of age on fluid intelligence is fully mediated by physical health
Bergman I, Almkvist O
Archives of gerontology and geriatrics 2013;57(1):100-9

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease
Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, et al
Neurobiology of aging 2012;33(1):198.e1-14

Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease
Eriksdotter-jönhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, Andreasen N, et al
Dementia and geriatric cognitive disorders 2012;33(1):18-28

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG
Carter Sf, Schöll M, Almkvist O, Wall A, Engler H, Långström B, et al
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(1):37-46

Individual variability and environmental characteristics influence older adults' abilities to manage everyday technology
Malinowsky C, Almkvist O, Nygård L, Kottorp A
International psychogeriatrics 2012;24(3):484-95

Is Loss in Odor Sensitivity Inevitable to the Aging Individual? A Study of "Successfully Aged" Elderly
Nordin S, Almkvist O, Berglund B
CHEMOSENSORY PERCEPTION 2012;5(2):188-196

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, et al
Neurology 2012;79(3):229-36

Psychometric data on the Eyes Test, the Faux Pas Test, and the Dewey Social Stories Test in a population-based Swedish adult sample
Soderstrand P, Almkvist O
NORDIC PSYCHOLOGY 2012;64(1):30-43

Word fluency performance and strategies in children with cochlear implants: age-dependent effects?
Löfkvist U, Almkvist O, Lyxell B, Tallberg Im
Scandinavian journal of psychology 2012;53(6):467-74

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo
Darreh-shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, et al
Neurobiology of aging 2011;32(12):2320.e15-32

Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation
Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, et al
Neurobiology of aging 2011;32(8):1388-99

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease
Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, et al
Brain : a journal of neurology 2011;134(Pt 1):301-17

Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects
Norberg J, Graff C, Almkvist O, Ewers M, Frisoni Gb, Frölich L, et al
Dementia and geriatric cognitive disorders 2011;32(2):135-42

Self- and informant ratings of personality in mild cognitive impairment, reviewed
Ausén B, Edman G, Almkvist O, Bogdanovic N
Dementia and geriatric cognitive disorders 2011;32(6):387-93

Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers
Schöll M, Almkvist O, Bogdanovic N, Wall A, Långström B, Viitanen M, et al
Journal of Alzheimer's disease : JAD 2011;24(3):495-506

Ability to manage everyday technology: a comparison of persons with dementia or mild cognitive impairment and older adults without cognitive impairment
Malinowsky C, Almkvist O, Kottorp A, Nygård L
Disability and rehabilitation. Assistive technology 2010;5(6):462-9

Biased Recognition of Positive Faces in Aging and Amnestic Mild Cognitive Impairment
Werheid K, Gruno M, Kathmann N, Fischer H, Almkvist O, Winblad B
PSYCHOLOGY AND AGING 2010;25(1):1-15

Early cognitive impairment in a subset of patients with presumed low-grade glioma
Ek L, Almkvist O, Wiberg Mk, Stragliotto G, Smits A
Neurocase 2010;16(6):503-11

High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters
Forsberg A, Almkvist O, Engler H, Wall A, Långström B, Nordberg A
Current Alzheimer research 2010;7(1):56-66

Cognitive Decline From Estimated Premorbid Status Predicts Neurodegeneration in Alzheimer's Disease
Almkvist O, Tallberg Im
NEUROPSYCHOLOGY 2009;23(1):117-24

Personality features in subjective cognitive impairment and mild cognitive impairment--early indicators of dementia?
Ausén B, Edman G, Almkvist O, Bogdanovic N
Dementia and geriatric cognitive disorders 2009;28(6):528-35

Clinical and neuropathological features of the Arctic APP gene mutation causing early-onset Alzheimer disease
Basun H, Bogdanovic N, Ingelsson M, Almkvist O, Naslund J, Axelman K, et al
ARCHIVES OF NEUROLOGY 2008;65(4):499-505

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, et al
ANNALS OF NEUROLOGY 2008;63(5):621-31

Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing
Vannini P, Lehmann C, Dierks T, Jann K, Viitanen M, Wahlund Lo, et al
NEUROBIOLOGY OF DISEASE 2008;31(3):287-97

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
Andersson C, Blennow K, Almkvist O, Andreasen N, Engfeldt P, Johansson Se, et al
NEUROBIOLOGY OF AGING 2008;29(10):1466-73

Inhibition of acetylcholinesterase in CSF versus brain assessed by C-11-PMP PET in AD patients treated with galantamine
Darreh-shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, et al
NEUROBIOLOGY OF AGING 2008;29(2):168-84

PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al
NEUROBIOLOGY OF AGING 2008;29(10):1456-65

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD
Kadir A, Darreh-shori T, Almkvist O, Wall A, Grut M, Strandberg B, et al
NEUROBIOLOGY OF AGING 2008;29(8):1204-17

Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease
Larsson Mu, Almkvist O, Luszcz Ma, Wahlin Tbr
NEUROPSYCHOLOGY 2008;22(5):596-605

Changes in brain C-11-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET
Kadir A, Darreh-shori T, Almkvist O, Wall A, Langstrom B, Nordberg A
PSYCHOPHARMACOLOGY 2007;191(4):1005-14

Differential CSF biomarker levels in APOE-epsilon 4-positive and -negative patients with memory impairment
Andersson C, Blennow K, Johansson Se, Almkvist O, Engfeldt P, Lindau M, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2007;23(2):87-95

Estimation of premorbid cognitive function based on word knowledge: The Swedish Lexical Decision Test (SLDT)
Almkvist O, Adveen M, Henning L, Tallberg Im
SCANDINAVIAN JOURNAL OF PSYCHOLOGY 2007;48(3):271-9

Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test
Claesson Im, Ytterberg C, Johansson S, Almkvist O, Von Koch L
MULTIPLE SCLEROSIS 2007;13(2):272-4

Reduced neuronal efficacy in progressive mild cognitive impairment: A prospective fMRI study on visuospatial processing
Vannini P, Almkvist O, Dierks T, Lehmann C, Wahlund Lo
PSYCHIATRY RESEARCH-NEUROIMAGING 2007;156(1):43-57

Selective decline in information processing in subgroups of multiple sclerosis: An 8-year longitudinal study
Bergendal G, Fredrikson S, Almkvist O
EUROPEAN NEUROLOGY 2007;57(4):193-202

The importance of impaired physical health and age in normal cognitive aging
Bergman I, Blomberg M, Almkvist O
SCANDINAVIAN JOURNAL OF PSYCHOLOGY 2007;48(2):115-25

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon 4 allele, in relation to cognitive function and cerebral glucose metabolism
Darreh-shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A
NEUROBIOLOGY OF DISEASE 2006;24(2):326-33

Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients
Andersson C, Lindau M, Almkvist O, Engfeldt P, Johansson Se, Jonhagen Me
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2006;21(4):251-9

Increased sensitivity in mapping task demand in visuospatial processing using reaction-time-dependent hemodynamic response predictors in rapid event-related fMRI
Lehmann C, Vannini P, Wahlund Lo, Almkvist O, Dierks T
NEUROIMAGE 2006;31(2):505-12

Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease
Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, Langstrom B, et al
JOURNAL OF NEURAL TRANSMISSION 2006;113(2):205-18

PET imaging of cortical C-11-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease
Kadir A, Almkvist O, Wall A, Langstrom B, Nordberg A
PSYCHOPHARMACOLOGY 2006;188(4):509-20

Reading words with irregular decoding rules: A test of premorbid cognitive function?
Tallberg Im, Wenneborg K, Almkvist O
SCANDINAVIAN JOURNAL OF PSYCHOLOGY 2006;47(6):531-9

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al
BRAIN 2006;:2856-66

Analysis of cognitive dysfunction in patients with low-grade glioma
Ek L, Smits A, Pahlson A, Almkvist O
JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS 2005;12(2):165-173

Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup
Wahlund Lo, Almkvist O, Blennow K, Engedahl K, Johansson A, Waldemar G, et al
Topics in magnetic resonance imaging : TMRI 2005;16(6):427-37

Insidious cognitive decline in CADASIL
Amberla K, Walijas M, Tuominen S, Almkvist O, Poyhonen M, Tuisku S, et al
STROKE 2004;35(7):1598-602

Mild cognitive impairment: a cross-national comparison
Arnaiz E, Almkvist O, Ivnik Rj, Tangalos Eg, Wahlund Lo, Winblad B, et al
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 2004;75(9):1275-80

Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund Lo, et al
JOURNAL OF INTERNAL MEDICINE 2004;256(3):240-6

Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients
Almkvist O, Darreh-shori T, Stefanova E, Spiegel R, Nordberg A
EUROPEAN JOURNAL OF NEUROLOGY 2004;11(4):253-61

Task demand modulations of visuospatial processing measured with functional magnetic resonance imaging
Vannini P, Almkvist O, Franck A, Jonsson T, Volpe U, Wiberg Mk, et al
NEUROIMAGE 2004;21(1):58-68

Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid(1-42) (CSF-A beta 42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients
Stefanova E, Blennow K, Almkvist O, Hellstrom-lindahl E, Nordberg A
NEUROSCIENCE LETTERS 2003;338(2):159-63

Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment
Almkvist O, Axelman K, Basun H, Jensen M, Viitanen M, Wahlund Lo, et al
ACTA NEUROLOGICA SCANDINAVICA 2003;:77-82

Cognitive syndrome(s) in preclinical and clinical vascular dementia
Almkvist O
INTERNATIONAL PSYCHOGERIATRICS 2003;:127-31

Impaired motor speed, visuospatial episodic memory and verbal fluency characterize cognition in long-term stroke survivors: The Tromso study
Engstad T, Almkvist O, Viitanen M, Arnesen E
NEUROEPIDEMIOLOGY 2003;22(6):326-31

License suspension revisited: A 3-year follow-up study of older drivers
Lundberg C, Hakamies-blomqvist L, Almkvist O, Johansson K
JOURNAL OF APPLIED GERONTOLOGY 2003;22(4):427-444

Life situation, coping and quality of life in people with high and low risk of developing Alzheimer's disease
Axelman K, Lannfelt L, Almkvist O, Carlsson M
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2003;16(4):220-8

Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease
Arnaiz E, Almkvist O
ACTA NEUROLOGICA SCANDINAVICA 2003;:34-41

Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease
Lindau M, Jelic V, Johansson Se, Andersen C, Wahlund Lo, Almkvist O
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2003;15(2):106-14

The assessment of fitness to drive after a stroke: The Nordic Stroke Driver Screening Assessment
Lundberg C, Caneman G, Samuelsson Sm, Hakamies-blomqvist L, Almkvist O
SCANDINAVIAN JOURNAL OF PSYCHOLOGY 2003;44(1):23-30

Visual rating of age-related white matter changes on magnetic resonance imaging - Scale comparison, interrater agreement, and correlations with quantitative measurements
European Task Force Age Related, Kapeller P, Barber R, Vermeulen Rj, Ader H, Scheltens P, et al
STROKE 2003;34(2):441-5

Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment
Huang Cr, Wahlund Lo, Almkvist O, Elehu D, Svensson L, Jonsson T, et al
NEUROIMAGE 2003;19(3):1137-44

Cognitive functioning in Alzheimer's disease and vascular dementia: Further evidence for similar patterns of deficits
Fahlander K, Wahlin A, Almkvist O, Backman L
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY 2002;24(6):734-44

Conversion from preclinical to clinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation
Almkvist O, Axelman K, Basun H, Wahlund Lo, Lannfelt L
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 2002;:117-25

Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity
Persson J, Hasselstrom J, Maurset A, Oye I, Svensson Jo, Almqvist O, et al
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2002;57(12):869-75

Semantic range and relevance of emotive utterances in patients with frontotemporal degeneration
Tallberg Im, Persson H, Wangmar L, Wahlund Lo, Almkvist O
BRAIN AND LANGUAGE 2002;82(2):146-58

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months
Darreh-shori T, Almkvist O, Guan Zz, Garlind A, Strandberg B, Svensson Al, et al
NEUROLOGY 2002;59(4):563-72

Confabulation and memory in patients with Alzheimer's disease
Tallberg Im, Almkvist O
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY 2001;23(2):172-84

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment
Arnaiz E, Jelic V, Almkvist O, Wahlund Lo, Winblad B, Valind S, et al
NEUROREPORT 2001;12(4):851-5

Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon 4
Ingelson M, Fabre Sf, Lilius L, Andersen C, Viitanen M, Almkvist O, et al
NEUROREPORT 2001;12(5):905-9

Responder characteristics to a single oral dose of cholinesterase inhibitor: A double-blind placebo-controlled study with tacrine in Alzheimer patients
Almkvist O, Jelic V, Amberla K, Hellstrom-lindahl E, Meurling L, Nordberg A
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2001;12(1):22-32

White matter lesions impair initiation of FAS flow
Fernaeus Se, Almkvist O, Bronge L, Ostberg P, Hellstrom A, Winblad B, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2001;12(1):52-6

First symptoms - Frontotemporal dementia versus Alzheimer's disease
Lindau M, Almkvist O, Kushi J, Boone K, Johansson Se, Wahlund Lo, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2000;11(5):286-93

Functional brain imaging as a looking-glass into the degraded brain: reviewing evidence from Alzheimer disease in relation to normal aging
Almkvist O
ACTA PSYCHOLOGICA 2000;105(2-3):255-77

Functional changes in brain activity during priming in Alzheimer's disease
Backman L, Almkvist O, Nyberg L, Andersson J
JOURNAL OF COGNITIVE NEUROSCIENCE 2000;12(1):134-41

Outcome measures in Alzheimer's disease: Do they go far enough?
Winblad B, Wimo A, Almkvist O
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2000;:3-10

Psychometric discrimination of Alzheimer's disease and mild cognitive impairment
Arnaiz E, Blomberg M, Fernaeus Se, Wahlund Lo, Winblad B, Almkvist O
ALZHEIMERS REPORTS 2000;3(2):97-104

Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease
Jelic V, Johansson Se, Almkvist O, Shigeta M, Julin P, Nordberg A, et al
NEUROBIOLOGY OF AGING 2000;21(4):533-40

Activity of acetylcholinesterase in CSF increases in Alzheimer's patients after treatment with tacrine
Nordberg A, Hellstrom-lindahl E, Almkvist O, Meurling L
ALZHEIMERS REPORTS 1999;2(6):347-352

A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation
Wahlund Lo, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 1999;10(6):526-33

Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease
Backman L, Andersson Jlr, Nyberg L, Winblad B, Nordberg A, Almkvist O
NEUROLOGY 1999;52(9):1861-70

Cognitive support at episodic encoding and retrieval: Similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients
Almkvist O, Fratiglioni L, Aguero-torres H, Viitanen M, Backman L
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY 1999;21(6):816-30

Diagnostic accuracies of quantitative EEG and PET in mild Alzheimer's disease
Jelic V, Wahlund Lo, Almkvist O, Johansson Se, Shigeta M, Winblad B, et al
ALZHEIMERS REPORTS 1999;2(5):291-298

Early diagnosis of Alzheimer dementia based on clinical and biological factors
Almkvist O, Winblad B
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 1999;:3-9

Impairment of neocortical metabolism predicts progression in Alzheimer's disease
Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 1999;10(6):494-504

Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation
Julin P, Almkvist O, Basun H, Lannfelt L, Svensson L, Winblad B, et al
ALZHEIMER DISEASE & ASSOCIATED DISORDERS 1998;12(1):49-53

[Cognitive and affective dysfunction in MS]
Bergendal G, Almkvist O, Fredrikson S
Nordisk medicin 1998;113(10):355-7

Cognitive and behavioral differentiation of frontal lobe degeneration of the non-Alzheimer type and Alzheimer's disease
Lindau M, Almkvist O, Johansson Se, Wahlund Lo
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 1998;9(4):205-13

Impairments of some cognitive functions are common in crash-involved older drivers
Lundberg C, Hakamies-blomqvist L, Almkvist O, Johansson K
ACCIDENT ANALYSIS AND PREVENTION 1998;30(3):371-7

Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease
Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A
NEUROSCIENCE LETTERS 1998;254(2):85-8

Mild cognitive impairment - an early stage of Alzheimer's disease?
Almkvist O, Basun H, Backman L, Herlitz A, Lannfelt L, Small B, et al
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 1998;:21-9

Word production: Dissociation of two retrieval modes of semantic memory across time
Fernaeus Se, Almkvist O
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY 1998;20(2):137-43

Bilateral temporal lobe volume reduction parallels cognitive impairment in progressive aphasia
Andersen C, Dahl C, Almkvist O, Ostberg P, Julin P, Wahlund Lo
ARCHIVES OF NEUROLOGY 1997;54(10):1294-9

Brain activation in young and older adults during implicit and explicit retrieval
Backman L, Almkvist O, Andersson J, Nordberg A, Winblad B, Reineck R, et al
JOURNAL OF COGNITIVE NEUROSCIENCE 1997;9(3):378-91

Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation
Almkvist O, Basun H, Wagner Sl, Rowe Ba, Wahlund Lo, Lannfelt L
ARCHIVES OF NEUROLOGY 1997;54(5):641-4

Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia
Basun H, Almkvist O, Axelman K, Brun A, Campbell Ta, Collinge J, et al
ARCHIVES OF NEUROLOGY 1997;54(5):539-44

Cognitive predictors of incident Alzheimer's disease: A prospective longitudinal study
Small Bj, Herlitz A, Fratiglioni L, Almkvist O, Backman L
NEUROPSYCHOLOGY 1997;11(3):413-20

Detection of mild dementia in community surveys - Is it possible to increase the accuracy of our diagnostic instruments?
Herlitz A, Small Bj, Fratiglioni L, Almkvist O, Viitanen M, Backman L
ARCHIVES OF NEUROLOGY 1997;54(3):319-24

EEG-microstates in mild memory impairment and Alzheimer's disease: Possible association with disturbed information processing
Dierks T, Jelic V, Julin P, Maurer K, Wahlund Lo, Almkvist O, et al
JOURNAL OF NEURAL TRANSMISSION 1997;104(4-5):483-95

Extradural morphine gives better pain relief than patient-controlled i.v. morphine after hysterectomy
Eriksson-mjöberg M, Svensson Jo, Almkvist O, Olund A, Gustafsson Ll
British journal of anaesthesia 1997;78(1):10-6

Extradural morphine gives better pain relief than patient-controlled iv morphine after hysterectomy
Erikssonmjoberg M, Svensson Jo, Almkvist O, Olund A, Gustafsson Ll
BRITISH JOURNAL OF ANAESTHESIA 1997;78(1):10-16

Global Dimensional Complexity of multichannel EEG in mild Alzheimer's disease and age-matched cohorts
Yagyu T, Wackermann J, Shigeta M, Jelic V, Kinoshita T, Kochi K, et al
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 1997;8(6):343-7

Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease
Nordin S, Almkvist O, Berglund B, Wahlund Lo
ARCHIVES OF NEUROLOGY 1997;54(8):993-8

Tone duration discrimination in demented, memory-impaired, and healthy elderly
Hellstrom A, Almkvist O
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 1997;8(1):49-54

Word production: Dissociation across time of working and semantic memory contributions
Almkvist O, Fernaeus Se
BRAIN AND COGNITION 1997;35(3):385-387

A follow up study of five cases of aluminosis
Sjogren B, Ljunggren Kg, Almkvist O, Frech W, Basun H
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH 1996;68(3):161-4

Apolipoprotein E epsilon 4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease
Algotsson A, Nordberg A, Lannfelt L, Almkvist O, Winblad B
ARCHIVES OF GERONTOLOGY AND GERIATRICS 1996;22(3):223-32

MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life
Wahlund Lo, Almkvist O, Basun H, Julin P
MAGNETIC RESONANCE IMAGING 1996;14(6):601-8

Neuropsychological assessment of dementia: State of the art
Almkvist O, Brane G, Johanson A
ACTA NEUROLOGICA SCANDINAVICA 1996;:45-9

Neuropsychological features of early Alzheimer's disease: Preclinical and clinical stages
Almkvist O
ACTA NEUROLOGICA SCANDINAVICA 1996;:63-71

Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment
Jelic V, Shigeta M, Julin P, Almkvist O, Winblad B, Wahlund Lo
DEMENTIA 1996;7(6):314-23

EEG IN SUCCESSFUL AGING - A 5-YEAR FOLLOW-UP-STUDY FROM THE 8TH TO 9TH DECADE OF LIFE
Shigeta M, Julin P, Almkvist O, Basun H, Rudberg U, Wahlund Lo
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 1995;95(2):77-83

Neuropsychiatric function of housepainters with previous long-term heavy exposure to organic solvents
Lundberg I, Michelsen H, Nise G, Hogstedt C, Hogberg M, Alfredsson L, et al
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH 1995;:1-44

SKIN VESSEL REACTIVITY IS IMPAIRED IN ALZHEIMERS-DISEASE
Algotsson A, Nordberg A, Almkvist O, Winblad B
NEUROBIOLOGY OF AGING 1995;16(4):577-82

Visa alla publikationer